Tumor cells, releasing pro-inflammatory factors, are able to induce the activity of NF-kB (Nuclear Factor kappa B) in fibroblast cells which, in turn, induce the release of growth factors and cytokines in the adjacent extracellular matrix, enhancing an inflammatory microenvironment and promoting changes in the ECM. The gene discussed is NFKB1; the disease is neoplasm.